Afuco™ Anti-IL13 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H05) (CAT#: AFC-TAB-H05)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Humanized (from mouse) antibody to Human IL13. It is a humanized monoclonal antibody designed for the treatment of asthma.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
RNA Expression

Specifications

  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • ADCC enhanced antibody
  • Specificity
  • IL13 (interleukin 13, IL-13) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • FC, IP, ELISA, Neut, FuncS, IF
  • Conjugate
  • Unconjugated
  • Generic Name
  • Anrukinzumab
  • Related Disease
  • Ulcerative colitis (UC)

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • IL13; interleukin 13; interleukin-13; allergic rhinitis; ALRH; BHR1; Bronchial hyperresponsiveness 1 (bronchial asthma); IL 13; MGC116786; MGC116788; MGC116789; P600; Bronchial hyperresponsiveness-1 (bronchial asthma); IL-13;

Related Resources

  • Biosimilar Overview
  • Related Diseases
Please refer to Anrukinzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Anrukinzumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "anrukinzumab"

Anti-Human IL13 Recombinant Antibody (Anrukinzumab)
Recombinant Humanized (from mouse) antibody to Human IL13. Anrukinzumab (IMA-638) is a humanized monoclonal antibody designed for the treatment of asthma.
DrugMonitor™ Anti-Anrukinzumab Antibody (VS-1224-YC93)
Anrukinzumab has been used in clinical trials for diagnostic studies in asthma. The DrugMonitor™ Anti-Anrukinzumab Antibody (VS-1224-YC93) is an anti-drug antibody (ADA) against Anrukinzumab. This drug-based antibody is raised in mice immunized with the Anrukinzumab. The anti-Anrukinzumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Anrukinzumab in samples.

See other products for "IL13"

Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibody Products ScFv Antibody Products Mouse Antibody Products Human Antibody Products Chimeric Antibody Products Neutralizing Antibody Products Rabbit Monoclonal Antibody Products Fab Antibody Products IgG Antibody Products ADCC Enhanced Antibody Products Flow Cytometry (FC) related Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-H05. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare